Title: Combined Biosynthetic and Synthetic Production of Valuable Molecules
Description: Synthetic chemistry has played a pivotal role in the evolution of modern life. More recently, the emerging field of synthetic biology holds the promise to bring about a paradigm shift with designer microbes to renewably synthesize complex molecules in a fraction of the time and cost. Still, given synthetic chemistry’s superior parsing powers to access a greater number of unnatural end products and nature’s virtuosity at stitching a staggering palette of carbon frameworks with ease, a hybrid approach that leverages the respective strengths of the two fields could prove advantageous for the efficient production of valuable natural molecules and their analogs. In a first demonstration of the hybrid approach where the biosynthesized intermediate is not part of the target molecule’s biosynthetic pathway, we engineered E. coli to produce Z,E-farnesol, which we subsequently transformed into a library of novel analogs of the commercially important amber fragrance Ambrox®, including the first synthetic patchouli scent.

In a second demonstration of the hybrid approach, we produced the valuable tocotrienols (vitamin E) from yeast-produced geranylgeraniol in a single step C–C coupling with concomitant regioselective cycloetherification of the most proximal vinyl of the polyene, the first such process of its kind. The novel acid catalyst system that allowed for this unique regioselective cyclization holds promise as an asymmetric proton transfer tool and could open the door to facile asymmetric synthesis of vitamin E and other molecules.